Sun Pharmaceutical Industries Ltd.

BSE: 524715 | NSE: SUNPHARMA
Large Cap | Pharmaceuticals & Drugs
1664.70
-4.50 (-0.27%)
< Home < Back

Sun Pharma’s arm recalls 144 bottles of anti-depression drug from US market

Date: 20-10-2023

Sun Pharmaceutical Industries’ US-based subsidiary -- Sun Pharmaceutical Industries Inc has recalled 144 bottles of a generic anti-depression medicine from the US market due to a manufacturing issue. The company has initiated the recall for the affected lot of Bupropion Hydrochloride extended-release tablets due to failed dissolution specifications.  

The affected lot was manufactured at Sun Pharma's Halol-based plant in Gujarat and was distributed in the US by Sun Pharmaceutical Industries Inc, based in Princeton, New Jersy. Bupropion is a medication commonly used to treat depression. The US-based drug maker initiated the voluntary Class III nationwide (US) recall on October 4 this year.

Sun Pharmaceutical Industries is the world's fourth largest specialty generic pharmaceutical company and India's top pharmaceutical company.